Your browser doesn't support javascript.
loading
Microarray-based technologies for the discovery of selective, RNA-binding molecules.
Abulwerdi, Fardokht A; Schneekloth, John S.
Afiliação
  • Abulwerdi FA; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, United States; Basic Research Laboratory, National Cancer Institute, Frederick, MD, United States.
  • Schneekloth JS; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, United States. Electronic address: schneeklothjs@mail.nih.gov.
Methods ; 103: 188-95, 2016 07 01.
Article em En | MEDLINE | ID: mdl-27109057
The identification of small molecules that bind specifically to RNA is a challenge. However, the recent explosion in knowledge about the role RNA plays in a number of physiological processes apart from coding for protein sequences makes it a highly interesting target for chemical probes and therapeutics. One technology that has played an important role in the discovery of RNA-binding molecules is microarrays. Microarrays have been broadly employed to screen, profile, and quantify RNA interactions, and will likely play an important role in the discovery of new classes of ligands going forward. Here, we discuss the development of microarray technologies, including aminoglycoside, peptide, peptoid, and small molecule microarrays, and their use in studying RNA-interacting molecules.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise de Sequência com Séries de Oligonucleotídeos / Avaliação Pré-Clínica de Medicamentos Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise de Sequência com Séries de Oligonucleotídeos / Avaliação Pré-Clínica de Medicamentos Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article